Introduction
============

Due to advances in molecular characterization, the taxonomy of the genus *Nocardia* has been changing rapidly. This is especially true for the taxon *Nocardia* *asteroides* which has been known for many years to be heterogeneous although it comprises the most important human pathogens \[[@R16]\], \[[@R22]\], \[[@R23]\]. Since it is difficult to delineate new species within the classical species *Nocardia asteroides* solely on the basis of phenotypic characteristics its heterogeneity has long been taken into account by using the collective designation *Nocardia asteroides* complex \[[@R24]\], \[[@R22]\].

Using a comprehensive phenotypic characterization combined with numerical phenetic analyses *Nocardia farcinica* was the first species that could reliably be differentiated from the rest of the *N. asteroides* complex (*N. asteroides* type B according to Schaal et al. \[[@R20]\]). By the same set of phenotypic data it was also possible to delineate *Nocardia cyriacigeorgici* \[[@R32]\] as *N. asteroides* type A1 \[[@R20]\].

Further newly recognized species are *N. abscessus* (formerly *N. asteroides* type A2) \[[@R20]\], \[[@R31]\] and *N. nova, N. paucivorans, N. africana* and *N. veterana* (all formerly included in the *N. asteroides* type A3 group) \[[@R20]\], \[[@R30]\]. Among these species *N. farcinica* is of special importance because of its broad natural resistance to numerous antibiotics, including sulpha drugs and cotrimoxazole. Of further special interest is the pronounced tendency of *N. farcinica* to disseminate to the brain, kidneys, joints, bone and eyes \[[@R21]\]. Other Nocardia species known to cause human disease are *N. brasiliensis, N. otitiscaviarum* and *N. transvalensis*. These species are mainly found in mycetoma lesions and have incidentally been isolated from immunocompromised patients with extensive disease. The distribution and medical significance of *Nocardia abscessus* \[[@R31]\] as well as the syndromes it can cause, cannot as yet be conclusively evaluated. The following case report shall hence draw attention to *N. abscessus* in order to be able to close the given scientific gap and to be aware of *nocardia* infections at immunocompromised patients to start effective prevention measures.

Case Report
===========

**Status:** 49 year-old patient suspected to have bronchial carcinoma; good general and dietary condition; adapted examination unremarkable both neurologically and medically; no signs of immunosuppression from laboratory chemistry.

**History:**Longer presence of latent hyperthyroidism in multifocal thyroid autonomy and COPD known.

**Course:** First hospitalisation with diagnosis of "peripheral bronchial carcinoma of the left superior pulmonary lobe"; histologically macrocellular, poorly differentiated squamous cell carcinoma; classified stage T2 NX.M1.

Computer tomography established right parasagittal cerebral metastasis. Follow-up examinations revealed widespread pulmonary metastases.

**Therapy:** Cerebral radiation after one month, cytostatic chemotherapy with cisplatin and etoposid 3 resp. 4 month after diagnosis.

**Further course:** Exacerbation of COPD with partial respiratory insufficiency resulted in emergency admission after half a year. Pneumonic infiltrates were abundant in the region of the left inferior pulmonary lobe upon X-ray. In consequence, high-dose antiobstructive steroid therapy was administered, as well as the antibiotic combination tazobactam/piperacillin. Sputum and blood cultures revealed no microbial growth.

Four weeks post-admission spontaneous an abscess in the left femoral region developed. Sonographically a liquid structure of 4 cm in diameter could be depicted. Upon incision resulted extensive pus emptying. Subsequently repeated antiseptic lavages were performed. This therapy was only followed by a moderate wound healing with formation of granulation tissue and wound closure appeared 8 month after the start of therapy and after multiple surgical local debriding interventions.

**Microbiology:** Identification was performed at the Actinomycetes Consultant Laboratory at the Institute for Medicinal Microbiology and Immunology of the University of Bonn. Microbiological and molecular biological evidences was given for *N. abscessus*. The results from routine susceptibility testing revealed susceptible to penicillin, ampicillin, amoxicillin/clavulanic acid, cefotiam, cefuroxime; resistant to trimethoprim/sulfamethoxazole.

In sum, the strain (designated IMMIB D-1873/99) was isolated four times from a deep wound of the left thigh of the patient on columbia blood agar in the course of disease. On this medium the organism formed well developed colonies which consisted of creamy to yellow-coloured substrate mycelia firmly embedded in the agar, and which bore white aerial hyphae. No diffusible pigments were observed. Microscopic examination revealed the presence of filamentous to rod-shaped elements which stained Gram-positive and partially acid fast after staining by the Ziehl-Neelsen method.

Chemotaxonomical analysis of the cell wall components of the isolate revealed all the properties which have hitherto been characteristic of the genus *Nocardia*. As with all nocardiae it has the cell wall type IV according to Lechevalier and Lechevalier \[[@R13]\] (meso-diaminopimelic acid, arabinose and galactose) as well as nocardomycolic acids. The other chemotaxonomic markers are also typical of nocardiae.

The almost complete 16S rRNA gene sequence (1486 nucleotides) was determined in this study. Sequence comparison using the ARB Database \[[@R14]\] revealed that the 16S rRNA gene sequence of isolate IMMIB D-1873/99 displayed 100% similarity to the reference sequences of *N. abscessus* (GenBank accession numbers, AF218292, AF218293, and AF218294). Furthermore, phylogenetic analysis using maximum-parsimony, neighbour-joining and maximum likelihood algorithms showed that isolate IMMIB D-1873/99 is closely associated with *N. abscessus* (Figure 1 [(Fig. 1)](#F1){ref-type="fig"}). These data definitely confirm the identification of isolate IMMIB D-1873/99 as *N. abscessus.*

The isolate is physiologically characterized by its ability to utilize citrate, maltose and sucrose as carbon sources and by its inability to hydrolyze esculin (Table 1 [(Tab. 1)](#T1){ref-type="fig"}). Variations in utilizing rhamnose initially led to the consideration that there could exist two different subspecies, as rhamnose utilization by nocardiae in itself is a very stable characteristic. The 16S rDNA sequence analyses, as well as the DNA-DNA pairing results of four different members of the species do not support the delineation of two subspecies, however.

In terms of resistance to antibacterial drugs, *N. abscessus* behaves like other members of the *N. asteroides* complex: it is much more susceptible than *N. farcinica* or*N. brasiliensis*, for instance \[[@R28]\]. The thigh isolate showed the following susceptibility pattern using microscopic reading of the standard tests applied in this study: susceptible to amoxicillin/clavulanic acid, imipenem, amikacin, gentamicin and tetracyclines; intermediary for tobramycin; resistant to trimethoprim/sulfamethoxazole, vancomycin, erythromycin, ampicillin, cefotaxime and ciprofloxacin. The results look less favourable than those obtained in the routine laboratory but detailed in vitro and in vivo studies \[[@R21]\] have shown that special adaptations of the susceptibility test procedures are required to make in vitro results clinically applicable.

Discussion
==========

Already on the occasion of its first description by Yassin et al. \[[@R31]\] *N. abscessus* was associated with human disease. Strains of this species were isolated from soft tissue abscesses or empyemas, pericarditis \[[@R29]\], endoprosthesis infection and fibular abscesses \[[@R31]\]. Immunosuppression could not be ascertained in all of the patients involved but seems to be one risk factor for infection, so that particularly in the case of reactivation the infection may take a fatal outcome \[[@R6]\]. The natural habitat of the pathogen as well as its geographical distribution is not known as yet. However, at least one strain was definitely not isolated in Europe; hence worldwide distribution can probably be postulated, as with other representatives of the *N. asteroides* complex. The same applies to soil as a natural habitat \[[@R1]\], \[[@R5]\], \[[@R10]\]. Because isolates of this species may have been misidentified as *N. asteroides* on the basis of phenotypic testing, it is quite likely that some isolates previously identified as *N. asteroides* may actually have been representatives of the species *N. abscessus*. Further studies to determine the incidence of this species would also help to determine the extent of its involvement in infections at other anatomic sites, its antibiotic susceptibility pattern as well as its geographic distribution and the impact of preventive measures. Analysis of a limited set of phenotypic characteristics and susceptibility testing results usually only allow the recognition of a group of organisms that are evolutionarily rather closely related. Like that of other pathogenetic *Nocardia* species, the identification of *N. abscessus* under routine conditions is not entirely straightforward because there is no commercial identification system which produces even approximately reliable results. It is therefore essential to use tests such as hydrolysis of complex substrates and carbon source utilization methods as in-house procedures possibly supplemented with molecular methods (e.g. 16S rDNA sequencing) in order to obtain a reliable identification result at the species level \[[@R1]\], \[[@R11]\], \[[@R24]\]. The members of the species *N. abscessus* examined so far fail to decompose esculin, casein, gelatin, hypoxanthine, tyrosine, and xanthine; they utilize citrate, maltose and rhamnose as carbon sources, but fail to utilize acetamide, alanine, gelatin, and proline as simultaneous carbon and nitrogen sources; they are susceptible to amoxicillin/clavulanic acid, imipenem, amikacin, gentamicin and tetracyclines. Strain IMMIB D-1873/99 shows biochemical characteristics which match this description.

However, it cannot be excluded that other as yet undescribed species share these characteristics as well. Therefore, for definitive identification of the various species of the *N. asteroides*complex, molecular methods such as 16S rRNA gene sequencing should be used. The 16S rDNA sequence of isolate IMMIB D-1873/99 shows 100% similarity to the 16S rDNA sequences of the type strain of *N. abscessus* indicating that strain IMMIB

D-1873/99 is phylogenetically very closely related to or identical with this species.

Infections by *N. abscessus* have only been reported in five patients up to now in Japan \[[@R9]\], in one German patient who developed a mycetoma after a road accident \[[@R6]\] and in a disseminated infection in an HIV-infected Argentinian patient \[[@R3]\] but the number of cases reported in the literature is increasing \[[@R26]\]. This might be due to an absolute increase in the number of immunocompromised patients but also to improvement in laboratory techniques to detect nocardiosis. Host resistance to nocardial infection depends primarily on the activity of neutrophils and then the cell-mediated immune response. The most common predisposing factors to opportunistic Nocardia infections are long-term steroid usage e.g. in transplant patients, chronic obstructive pulmonary disease (COPD), neoplastic disease, and human immunodeficiency virus (HIV) infection \[[@R17]\], \[[@R7]\].

Our patient represents a further case of infection with unusual *Nocardia* and the soft tissue infection certainly results from dissemination after primary lung infection (air born infection). No specific risk factor (RKI \[[@R12]\]) (except immunosuppression by lung cancer) regarding *Nocardia* exposure like close contact to soil and dust contamination can be elicited.

Chemoprophylaxis (of post transplant patients) for preventing urinary tract infections, pneumocystis and *Nocardia* infections include cotrimoxazole, it is be used for 6--12 months after transplantation, the period of maximum risk for PCP and *Nocardia* \[[@R8]\], \[[@R2]\] but in our case, this drug showed in vitro resistance to cotrimoxazole and therefore has been omitted for preventive drug therapy. Otherwise, trimethoprim/sulfamethoxazole shows good in vitro activities against most of the unusual*Nocardia* isolates. Therefore amikazin, as another option for antibiotic infection prevention (and therapy), an antibiotic with also good therapeutic results in Nocardiosis was tested susceptible at our patient and could have been applied \[[@R18]\] .

The second emphasis of preventive measures, the strict restriction of soil and aerosol contact, especially to builder\'s dust, would have been the hygienic measure of choice for the patient. In the presence of the long course of disease this measure could only be realized regarding his hospitalisation periods but not at all in the meantime at home.

Conclusions
===========

In the light of unusual but often complicated and life-threatening *Nocardia* soft tissue infections, accurate identification of *Nocardia* species using molecular techniques is important to make the diagnosis, to elucidate the epidemiology and to start effective therapy as well and accurate prevention measures. The reliable differentiation of *N. abscessus* from other *Nocardia* species requires special diagnostic procedures and some experience in handling aerobic pathogenic actinomycetes. The case report presented here describes *N. abscessus* as a pathogen in endogenous and exogenous immunosuppression (bronchial carcinoma treated with chemotherapy).
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